Loading clinical trials...
Loading clinical trials...
Graves' disease is the main cause of hyperthyroidism. Graves' disease has a prevalence of 0.5% in the general population. As a non-surgical treatment, antithyroid drug (ATD) and radioactive iodine tre...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seoul St. Mary's Hospital
NCT07333677 · Graves' Disease
NCT06418919 · Relapsed Graves' Disease, Thyroid; Functional Disturbance, and more
NCT06426758 · Graves Disease, Graves' Disease in Remission, and more
NCT01950260 · Graves' Disease
NCT02727738 · Graves' Disease
Seoul St. Mary hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions